Clovis Oncology Inc (NASDAQ:CLVS)
| 12.10 Delayed Data As of Dec 10 |  +1.39 / +12.98%Today’s Change | 2.93 Today|||52-Week Range 32.05 | -32.63% Year-to-Date |
Latest CLVS News | Press Releases
| Is Clovis Oncology Really a Buyout Candidate? Dec 03 / MotleyFool.com - Paid Partner Content | 3 Top Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.71 |
| Today’s open | 11.00 |
| Day’s range | 10.80 - 12.60 |
| Volume | 17,918,909 |
| Average volume (3 months) | 7,841,208 |
| Market cap | $527.3M |
Data as of 4:00pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | +3.97% |
| Earnings growth (this year) | -2.06% |
| Earnings growth (next 5 years) | +32.06% |
| Revenue growth (last year) | +71.84% |
| P/E ratio | NM |
| Price/Sales | 9.80 |
| Price/Book | 3.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACIUAC Immune SA | -0.31 | -3.58% |
| GNFTGenfit SA | +0.58 | +3.76% |
| BDSIBioDelivery Sciences... | +0.06 | +0.94% |
| CYTKCytokinetics Inc | -0.14 | -1.45% |
Data as of 4:00pm ET, 12/10/2019
Financials
| Next reporting date | February 25, 2020 |
| EPS forecast (this quarter) | -$1.68 |
| Annual revenue (last year) | $95.4M |
| Annual profit (last year) | -$368.0M |
| Net profit margin | -385.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
